Satish joined Advent in January 2022 after serving as a CEO of BioMotiv, an early-stage investment fund.

Satish did his postdoctoral research at Whitehead Institute at MIT. Satish was a co-founder and CEO of NeoGenesis (acquired by Schering-Plough, now Merck), Co-founder and President of Verastem (NADAQ: VSTM) and co-founder of Elicio Therapeutics.

He also served as Vice President and Site Head at Schering-Plough Research Institute in Cambridge, Massachusetts, and Vice President at Bristol-Myers Squibb.

He obtained a PhD in Biochemistry from Punjab University in India.

Assistant: Bonita Theara
E: This email address is being protected from spambots. You need JavaScript enabled to view it.
T: +44 (0)20 7932 2157

Back